CNTMF
Price
$0.08
Change
-$0.01 (-11.11%)
Updated
Nov 14 closing price
11 days until earnings call
CRLBF
Price
$1.40
Change
-$0.04 (-2.78%)
Updated
Nov 14 closing price
118 days until earnings call
Ad is loading...

CNTMF vs CRLBF

Header iconCNTMF vs CRLBF Comparison
Open Charts CNTMF vs CRLBFBanner chart's image
Cansortium
Price$0.08
Change-$0.01 (-11.11%)
Volume$211.99K
CapitalizationN/A
Cresco Labs
Price$1.40
Change-$0.04 (-2.78%)
Volume$687.68K
CapitalizationN/A
CNTMF vs CRLBF Comparison Chart
Loading...
View a ticker or compare two or three
VS
CNTMF vs. CRLBF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTMF is a Hold and CRLBF is a Sell.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (CNTMF: $0.08 vs. CRLBF: $1.40)
Brand notoriety: CNTMF and CRLBF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CNTMF: 104% vs. CRLBF: 107%
Market capitalization -- CNTMF: $21.83M vs. CRLBF: $501.04M
CNTMF [@Pharmaceuticals: Other] is valued at $21.83M. CRLBF’s [@Pharmaceuticals: Other] market capitalization is $501.04M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTMF’s FA Score shows that 0 FA rating(s) are green whileCRLBF’s FA Score has 0 green FA rating(s).

  • CNTMF’s FA Score: 0 green, 5 red.
  • CRLBF’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTMF is a better buy in the long-term than CRLBF.

Price Growth

CNTMF (@Pharmaceuticals: Other) experienced а -14.06% price change this week, while CRLBF (@Pharmaceuticals: Other) price change was +9.38% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +56.20%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -6.95%.

Reported Earning Dates

CNTMF is expected to report earnings on May 05, 2025.

CRLBF is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+56.20% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
CRLBF($501M) has a higher market cap than CNTMF($21.8M). CRLBF YTD gains are higher at: 3.260 vs. CNTMF (-7.262). CNTMF has higher annual earnings (EBITDA): 6.79M vs. CRLBF (-16.73M). CRLBF has more cash in the bank: 88.8M vs. CNTMF (9.47M). CNTMF has less debt than CRLBF: CNTMF (94.5M) vs CRLBF (678M). CRLBF has higher revenues than CNTMF: CRLBF (822M) vs CNTMF (90M).
CNTMFCRLBFCNTMF / CRLBF
Capitalization21.8M501M4%
EBITDA6.79M-16.73M-41%
Gain YTD-7.2623.260-223%
P/E RatioN/AN/A-
Revenue90M822M11%
Total Cash9.47M88.8M11%
Total Debt94.5M678M14%
FUNDAMENTALS RATINGS
CRLBF: Fundamental Ratings
CRLBF
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

CNTMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTMF has been loosely correlated with TCNNF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTMF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTMF
1D Price
Change %
CNTMF100%
-6.25%
TCNNF - CNTMF
47%
Loosely correlated
-6.28%
VRNOF - CNTMF
38%
Loosely correlated
-7.29%
GTBIF - CNTMF
37%
Loosely correlated
-4.21%
CURLF - CNTMF
36%
Loosely correlated
-1.79%
CRLBF - CNTMF
34%
Loosely correlated
-2.78%
More

CRLBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TCNNF. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
-2.78%
TCNNF - CRLBF
75%
Closely correlated
-6.28%
TSNDF - CRLBF
75%
Closely correlated
-2.00%
CURLF - CRLBF
73%
Closely correlated
-1.79%
VRNOF - CRLBF
72%
Closely correlated
-7.29%
GTBIF - CRLBF
71%
Closely correlated
-4.21%
More